Tofacitinib Efficacy and Safety in Patients With Ankylosing Spondylitis by Prior Biologic Disease‐Modifying Antirheumatic Drug Use: A Post Hoc Analysis

Objective To evaluate the efficacy and safety of tofacitinib in patients with ankylosing spondylitis (AS) by prior biologic disease‐modifying antirheumatic drug (bDMARD) use. Methods Data from a placebo‐controlled, double‐blind study of patients with active AS were analyzed. Patients received tofaci...

Full description

Bibliographic Details
Main Authors: Atul Deodhar, Helena Marzo‐Ortega, Joseph Wu, Cunshan Wang, Oluwaseyi Dina, Keith S. Kanik, Lara Fallon, Lianne S. Gensler
Format: Article
Language:English
Published: Wiley 2023-12-01
Series:ACR Open Rheumatology
Online Access:https://doi.org/10.1002/acr2.11601